Amneal Pharmaceuticals, Inc. Class A Common Stock
$12.78
USD
Last updated on --.
24h volume2.13M
24h highest12.8100 USD
24h lowest12.5400 USD
24h Price movement+2.94%
AMRX recent prices
24 Hours
+2.94%+$0.365
30 days
-1.27%-$0.16
60 days
+4.73%+$0.56
90 days
-14.88%-$2.170
Key data
Previous close12.4200 USD
Market cap3.90B USD
Volume2.13M
P/E ratio31.950000
Dividend yield (TTM)0.01%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.38000 USD
Net income (FY)181.32M USD
Revenue (FY)3.05B USD
Last report date7 May 2026
About Amneal Pharmaceuticals, Inc. Class A Common Stock
Employees (FY)8.50K
Revenue per employee (FY)358.34K USD
Net income per employee (FY)21.33K USD
Listed onNasdaq
AMRX conversion tables
 |  |
|---|---|
| 0.5 AMRX | 6.392 USD |
| 1 AMRX | 12.78 USD |
| 5 AMRX | 63.92 USD |
| 10 AMRX | 127.85 USD |
| |
|---|---|
| 0.5 USD | 0.039108 AMRX |
| 1 USD | 0.078217 AMRX |
| 5 USD | 0.39108 AMRX |
| 10 USD | 0.78217 AMRX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
AMRX is trading at $12.78, +2.94% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AMRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AMRX is currently trading at $12.78, +2.94% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AMRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AMRX's P/E ratio is currently 31.950000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AMRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AMRX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Amneal Pharmaceuticals, Inc. Class A Common Stock's market cap is currently 3.90B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.13M
24h highest12.8100 USD
24h lowest12.5400 USD
24h Price movement+2.94%
Start trade with AMRX Perpetual
Sign up to trade